CI - Cigna Corporation

NYSE - NYSE Delayed Price. Currency in USD
153.30
-2.48 (-1.59%)
At close: 4:01PM EDT
Stock chart is not supported by your current browser
Previous Close155.78
Open155.00
Bid151.51 x 900
Ask155.79 x 1000
Day's Range152.29 - 156.90
52 Week Range141.95 - 226.61
Volume2,100,221
Avg. Volume1,948,041
Market Cap57.887B
Beta (3Y Monthly)1.02
PE Ratio (TTM)13.23
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.04 (0.03%)
Ex-Dividend Date2019-03-08
1y Target EstN/A
Trade prices are not sourced from all markets
  • How a health care 'hedge fund' run by ex-congressman plans to cut costs
    Yahoo Finance

    How a health care 'hedge fund' run by ex-congressman plans to cut costs

    The Healthcare Transformation Alliance, led by former N.J. Congressman Rob Andrews, has saved its members at least $400 million in overall health care spending.

  • Is Cigna (CI) Stock Undervalued Right Now?
    Zacks

    Is Cigna (CI) Stock Undervalued Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • 15 Large-Cap Stocks Betting Big on Mamp;A
    Kiplinger

    15 Large-Cap Stocks Betting Big on Mamp;A

    The right mergers and acquisitions (M&A;) can make a good company even better by opening up new markets, expanding capabilities and market share, and diversifying product lines.Not every deal is a guaranteed winner, but investors typically benefit from smart M&A.; A 2016 Booth Business School study found, on average, an increase in overall value for both the acquiring and acquired companies at the time of the merger, and a long-term rise in value for companies that made cash acquisitions.Consider the $81 billion merger between Exxon and Mobil in 1999 that created Exxon Mobil (XOM) - now a $300 billion goliath and the largest publicly traded energy company on U.S. exchanges. Or there's Walt Disney's (DIS) $6 billion buyout of Pixar in 2006. The studio's animated films have generated nearly $11 billion in worldwide box office alone, not accounting for merchandise and other related opportunities.Last year was an especially good year for corporate M&A; thanks to major catalysts provided by tax reform, low borrowing costs and a healthy stock market. Dealmaking hit near-record levels last year. According to Mergermarket, 5,718 transactions closed, and deal volume exceeded $1.5 trillion - the second-highest total ever. Also noteworthy was last year's surge in "mega-deals" - transactions valued at more than $10 billion. These included Keurig Dr. Pepper's (KDP) $27 billion acquisition of soft drink maker Dr. Pepper Snapple Group and pharmacy chain CVS Health's (CVS) $70 billion takeover of health insurance provider Aetna.Here are 15 large-cap stocks that are looking for big things out of their pending or recently closed M&A; deals. These mergers and acquisitions are either already sparking new life in the acquiring companies, or analysts and other market professionals expect them to do so over the coming years. SEE ALSO: The Berkshire Hathaway Portfolio: All 47 Buffett Stocks Explained

  • Investing.com

    Stocks - Boeing Boosts Dow While Investors Await Powell

    Investing.com – Investors are betting big on Boeing (NYSE:BA) for now, and the Dow Jones Industrial Average was the beneficiary on Thursday.

  • New York health insurer expanding to Georgia, five other states
    American City Business Journals

    New York health insurer expanding to Georgia, five other states

    Oscar Insurance Corp. expansion comes as other health insurers are expanding their Affordable Care Act plan offerings for next year.

  • Three state attorneys general challenge Trump on immigrant benefits
    Yahoo Finance

    Three state attorneys general challenge Trump on immigrant benefits

    The health care ecosystem could see the clock turn back on improvements to costs due the public charge rule.

  • Options Bulls Bet on a Bounce for Cigna Stock, Despite Dip
    Schaeffer's Investment Research

    Options Bulls Bet on a Bounce for Cigna Stock, Despite Dip

    Cigna stock is slightly lower on reports that it is selling its benefits insurance unit

  • Sources: Parkway West building up for sale
    American City Business Journals

    Sources: Parkway West building up for sale

    In what will likely be a good test of a market in which there has been few major office sales of late, 2000 Park Lane is up for sale. Sources familiar with the marketing of the property indicate the Parkway West complex is being shopped around by its owner, Atlanta Property Group, which bought it in a seven-building portfolio deal a little more than two years ago. The Pittsburgh property, totaling nearly 235,000 square feet and located in North Fayette, was the first buy of its kind by the company and is the only one listed outside its southern territory that extends from North Carolina through central Georgia and into Florida.

  • Exclusive: Cigna seeks sale of group benefits insurance business - sources
    Reuters

    Exclusive: Cigna seeks sale of group benefits insurance business - sources

    Cigna's move to shed it underscores its decision to focus on healthcare following its $54-billion acquisition of pharmacy benefits manager Express Scripts Holding Co last year. The Bloomfield, Connecticut-based company is working with an investment bank to run an auction for the group benefits business, the sources said.

  • What Makes Cigna (CI) a New Buy Stock
    Zacks

    What Makes Cigna (CI) a New Buy Stock

    Cigna (CI) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • Another 1% Rally Provides a Strong Start to the Week
    Zacks

    Another 1% Rally Provides a Strong Start to the Week

    Another 1% Rally Provides a Strong Start to the Week

  • Moody's

    Connecticut General Life Insurance Company -- Moody's announces completion of a periodic review of ratings of Cigna Corporation

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Cigna Corporation and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.

  • Radian Group (RDN) Okays Share Buyback Program Worth $200M
    Zacks

    Radian Group (RDN) Okays Share Buyback Program Worth $200M

    Radian Group's (RDN) new share repurchase program reflects effective capital deployment backed by solid financial position banking on strong core operations.

  • BioDelivery (BDSI) Earnings & Sales Beat Estimates in Q2
    Zacks

    BioDelivery (BDSI) Earnings & Sales Beat Estimates in Q2

    BioDelivery (BDSI) reports earnings against expectations of loss in Q2 and raises guidance for 2019.

  • Assurant (AIZ) Hits Fresh High: Is There Still Room to Run?
    Zacks

    Assurant (AIZ) Hits Fresh High: Is There Still Room to Run?

    Assurant (AIZ) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • Amazon's PillPack continues to battle against longtime players
    Yahoo Finance

    Amazon's PillPack continues to battle against longtime players

    Amazon's PillPack faces stiff competition against the likes of CVS and Walgreens.

  • Thomson Reuters StreetEvents

    Edited Transcript of CI.N earnings conference call or presentation 1-Aug-19 12:30pm GMT

    Q2 2019 Cigna Corp Earnings Call

  • Outlook for Health Insurance Industry Looks Sanguine
    Zacks

    Outlook for Health Insurance Industry Looks Sanguine

    Outlook for Health Insurance Industry Looks Sanguine

  • Reuters

    FOCUS-Patient groups push back against Gilead's pricey HIV prevention treatment

    Gilead Sciences Inc hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker faces opposition from an unusual source: patient advocates. Such groups have traditionally lobbied for insurance coverage of newer HIV drugs regardless of expense. A generic version of the current prevention pill, Truvada, is due in the United States in September 2020, which should bring down costs and give many more people access to the therapy, they say.

  • Buy CVS Health (CVS) Ahead of Q2 Earnings?
    Zacks

    Buy CVS Health (CVS) Ahead of Q2 Earnings?

    CVS Health (CVS) will be reporting their second quarter before the opening bell on Wednesday.

  • Barrons.com

    Cigna Stock Is Up Because a Bullish Analyst Sees Earnings Growth

    Shares of health insurance giant Cigna Corp. rose after Alliance Bernstein upgraded the stock’s rating, citing future earnings growth and a stock valuation that is too low.

  • Amazon and Pill Pack faces resistance from pharmacies
    Yahoo Finance Video

    Amazon and Pill Pack faces resistance from pharmacies

    Yahoo Finance's Anjalee Khemlani weighs on how Amazon and Pill Pack are facing resistance from pharmacies on YFi AM. She says, "right now, CVS and Walgreens are claiming that Pill Pack improperly obtained information of their customers … but there is no real hard evidence."